Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)

Radiotherapy and Oncology

Volumn 98, Issue 1, 2011, Pages 38-41

  Walsh, Lorraine ^a   Gillham, Charles ^a   Dunne, Mary ^a   Fraser, Ian ^a   Hollywood, Donal ^a   Armstrong, John ^a   Thirion, Pierre ^a  

^a ST LUKE S HOSPITAL   (Ireland)

Author keywords

Cetuximab; Head and neck; Radiotherapy; Toxicity

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; ENTERIC FEEDING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LOADING DRUG DOSE; MALE; MUCOSA INFLAMMATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION HAZARD; RASH; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; WEIGHT REDUCTION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PATIENT COMPLIANCE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 78651368497     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.11.009     Document Type: Article

References (15)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J Clin 49 1999 33 64 (Pubitemid 29094960)
2. T.G. Wendt, G.G. Grabenbauer, and C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study J Clin Oncol 16 1998 1318 1324
3. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16 (Pubitemid 30488207)
4. J. Bourhis, M. Lapeyre, and J. Tortochaux Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial J Clin Oncol 24 2006 2873 2878 (Pubitemid 46630588)
5. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
6. W. Budach, E. Bolke, and B. Homey Severe cutaneous reaction during radiation therapy with concurrent cetuximab N Engl J Med 357 2007 514 515 (Pubitemid 47204904)
7. M.E. Lacouture Mechanisms of cutaneous toxicities to EGFR inhibitors Nat Rev Cancer 6 2006 803 812
8. H.K. Lord, E. Junor, and J. Ironside Cetuximab is effective, but more toxic than reported in the Bonner trial Clin Oncol (R Coll Radiol) 20 2008 96
9. D.I. Pryor, S.V. Porceddu, and B.H. Burmeister Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer Radiother Oncol 90 2009 172 176
10. E. Bolke, P.A. Gerber, and G. Lammering Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab Strahlenther Onkol 184 2008 105 110 (Pubitemid 351231657)
11. A.R. Mydin, and J.G. Armstrong Acneiform rash secondary to cetuximab plus head and neck radiotherapy Radiother Oncol 85 2007 171
12. B. Berger, and C. Belka Severe skin reaction secondary to concomitant radiotherapy plus cetuximab Radiat Oncol 3 2008 5
13. C. Giro, B. Berger, and E. Bolke High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes Radiother Oncol 90 2009 166 171
14. D. Curran, J. Giralt, and P.M. Harari Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab J Clin Oncol 25 2007 2191 2197 (Pubitemid 46954642)
15. T.B. El-Abaseri, S. Putta, and L.A. Hansen Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor Carcinogenesis 27 2006 225 231 (Pubitemid 43159873)